HealthExec | Homepage

The U.S. Food and Drug Administration (FDA) has issued a new draft guidance designed to help applicants add clinically relevant information about QTc interval prolongation to the labeling of non-antiarrhythmic drugs

‘Gray market’ vendors hike up prices during drug shortages, leaving hospitals in a bind

Hospital executives find themselves in a challenging position—pay big bucks for hard-to-find medications or risk letting their patients down.

FDA warning letter details quality concerns, violations at Integra facility

The facility in question is responsible for producing collagen-based medical devices primarily used in wound care, soft tissue repair and complex reconstruction surgeries.

GPT-4, a new upgrade from the team behind ChatGPT, can help doctors with difficult diagnoses

The new and improved AI-based language model outperformed human clinicians in a new study published in JAMA Network Open.

GE Healthcare's Portrait Mobile wireless and wearable monitoring solution

GE HealthCare earns FDA clearance for new remote patient monitoring device

The newly cleared device was designed with patient freedom and flexibility in mind.

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

Race for AI dominance: 5 points to ponder about US v. China

AI that’s intended to let cars drive themselves can be repurposed to let tanks level cities. And AI can just as easily weaponize a virus as diagnose it. These are not secrets.

Around the web

Cardiovascular Business

FDA approves another GLP-1 pill for weight loss

The approval, made as part of a special FDA pilot program, took just 50 days.